Geoffrey M Bove Selected Research

Neuritis (Polyneuritis)

1/2020	Characterizing the Mechanical Properties of Ectopic Axonal Receptive Fields in Inflamed Nerves and Following Axonal Transport Disruption.
3/2019	Manual therapy prevents onset of nociceptor activity, sensorimotor dysfunction, and neural fibrosis induced by a volitional repetitive task.
1/2018	Time course of ongoing activity during neuritis and following axonal transport disruption.
10/2017	Group IV nociceptors develop axonal chemical sensitivity during neuritis and following treatment of the sciatic nerve with vinblastine.
11/2013	Disruption of fast axonal transport in the rat induces behavioral changes consistent with neuropathic pain.
5/2003	Paw withdrawal thresholds and persistent hindlimb flexion in experimental mononeuropathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geoffrey M Bove Research Topics

Disease

8	Inflammation (Inflammations) 05/2021 - 01/2008
6	Neuritis (Polyneuritis) 01/2020 - 05/2003
5	Fibrosis (Cirrhosis) 05/2021 - 03/2015
3	Cumulative Trauma Disorders (Repetitive Strain Injury) 01/2021 - 03/2015
3	Pain (Aches) 01/2012 - 07/2006
2	Hypersensitivity (Allergy) 01/2021 - 11/2013
1	Ileus 01/2013
1	Infertility (Sterility) 01/2012
1	Pheochromocytoma 10/2007
1	Neoplasms (Cancer) 10/2007
1	Low Back Pain (Lumbago) 10/2007
1	Wounds and Injuries (Trauma) 02/2002

Drug/Important Bio-Agent (IBA)

4	Vinblastine (Vinblastine Sulfate)FDA Link 01/2020 - 11/2013
3	Freund's AdjuvantIBA 10/2017 - 05/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 02/2002
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2013
2	Substance PIBA 03/2015 - 07/2006
1	Collagen Type I (Type I Collagen)IBA 05/2021
1	CollagenIBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2020
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 03/2019
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 03/2015
1	KinesinsIBA 11/2013
1	Colchicine FDA LinkGeneric 01/2008
1	CatecholaminesIBA 10/2007
1	CarrageenanIBA 05/2003

Therapy/Procedure

5	Musculoskeletal Manipulations (Manipulative Therapy) 05/2021 - 07/2011
1	Length of Stay 01/2013
1	Massage (Zone Therapy) 01/2013
1	Patient Readmission 01/2012
1	Axotomy 07/2006